Fujia: Completion of clinical trial registration for Class III medical devices.

Fujiki announcement, the company's third-class medical device product "recombinant type III human-collagen dressing" has passed clinical trial ethical review and completed filing at the Heilongjiang Provincial Drug Administration, and has entered the clinical trial stage. This product is used for post-operative wound repair assistance for laser and photon surgery, as well as repairing damaged skin barrier function for sensitive skin patients. Currently, there are relatively few similar medical device products and manufacturers in the medical aesthetics field domestically and internationally. The market is in a rapid development stage, with domestic production and sales growing rapidly and market demand continuing to increase. The market potential is considerable.